Skip to main content
https://pbs.twimg.com/media/FbF535TX0AAbMgY.jpg
Phase 2 RCTs are evaluating TLR 7 & TLR 8 blockade in SLE - BMS has afimetoran and Merck has enpatoran (both blocking TLR7/8) https://t.co/3TavS7NE99 https://t.co/lZyp1QLNqP
Dr. John Cush
26-08-2022
×